Additionally, Bardeesy and colleagues (41) showed that restoration of TET activity in an IDH-mutant cholangiocarcinoma tumor model restored downstream IFN-γ signaling and enhanced checkpoint inhibitor responses. This evidence concerns the gene IDH2 and cholangiocarcinoma.